Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naomi Iwasa

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Kidney International Reports|March 8, 2022
Germline Mutations for Kidney Volume in ADPKDHiroshi Kataoka, Rie Yoshida, Naomi Iwasa, et al.
Medicines (Basel, Switzerland)|March 18, 2020
High Serum Phosphate Level as a Risk Factor to Determine Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective StudyMasayo Sato, Hiroshi Kataoka, Yusuke Ushio, et al.
Scientific Reports|October 27, 2022
Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney diseaseHiroshi Kataoka, Hiroyuki Akagawa, Rie Yoshida, et al.
Gynecologic Oncology|July 17, 2021
ARID1A mutation/ARID1A loss is associated with a high immunogenic profile in clear cell ovarian cancerYuka Kuroda, Tatsuyuki Chiyoda, Miho Kawaida, et al.
Journal of Nephrology|February 5, 2024
Factors associated with early-onset intracranial aneurysms in patients with autosomal dominant polycystic kidney diseaseYusuke Ushio, Hiroshi Kataoka, Hiroyuki Akagawa, et al.
Scientific Reports|November 9, 2022
Machine learning for morbid glomerular hypertrophyYusuke Ushio, Hiroshi Kataoka, Kazuhiro Iwadoh, et al.
Plos One|November 16, 2020
Visceral to subcutaneous fat ratio as an indicator of a ≥30% eGFR decline in chronic kidney diseaseHiroshi Kataoka, Toshio Mochizuki, Kazuhiro Iwadoh, et al.
Journal of Atherosclerosis and Thrombosis|August 8, 2020
Maximum Carotid Intima-Media Thickness in Association with Renal OutcomesShun Manabe, Hiroshi Kataoka, Toshio Mochizuki, et al.
Clinical and Experimental Nephrology|February 17, 2021
Impact of visceral fat area in patients with chronic kidney diseaseShun Manabe, Hiroshi Kataoka, Toshio Mochizuki, et al.
Plos One|May 8, 2020
Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up studyHiroshi Kataoka, Mamiko Ohara, Tomo Suzuki, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Kidney International Reports|March 8, 2022
Germline Mutations for Kidney Volume in ADPKDHiroshi Kataoka, Rie Yoshida, Naomi Iwasa, et al.
Medicines (Basel, Switzerland)|March 18, 2020
High Serum Phosphate Level as a Risk Factor to Determine Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective StudyMasayo Sato, Hiroshi Kataoka, Yusuke Ushio, et al.
Scientific Reports|October 27, 2022
Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney diseaseHiroshi Kataoka, Hiroyuki Akagawa, Rie Yoshida, et al.
Gynecologic Oncology|July 17, 2021
ARID1A mutation/ARID1A loss is associated with a high immunogenic profile in clear cell ovarian cancerYuka Kuroda, Tatsuyuki Chiyoda, Miho Kawaida, et al.
Journal of Nephrology|February 5, 2024
Factors associated with early-onset intracranial aneurysms in patients with autosomal dominant polycystic kidney diseaseYusuke Ushio, Hiroshi Kataoka, Hiroyuki Akagawa, et al.
Scientific Reports|November 9, 2022
Machine learning for morbid glomerular hypertrophyYusuke Ushio, Hiroshi Kataoka, Kazuhiro Iwadoh, et al.
Plos One|November 16, 2020
Visceral to subcutaneous fat ratio as an indicator of a ≥30% eGFR decline in chronic kidney diseaseHiroshi Kataoka, Toshio Mochizuki, Kazuhiro Iwadoh, et al.
Journal of Atherosclerosis and Thrombosis|August 8, 2020
Maximum Carotid Intima-Media Thickness in Association with Renal OutcomesShun Manabe, Hiroshi Kataoka, Toshio Mochizuki, et al.
Clinical and Experimental Nephrology|February 17, 2021
Impact of visceral fat area in patients with chronic kidney diseaseShun Manabe, Hiroshi Kataoka, Toshio Mochizuki, et al.
Plos One|May 8, 2020
Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up studyHiroshi Kataoka, Mamiko Ohara, Tomo Suzuki, et al.
Pageof 3